Rare diseases
Investigational molecules
Locations
Back to Romania16 clinical trials in Bragadiru, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
RomaniaLong‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis
RomaniaA Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.
RomaniaAsthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate
RomaniaEfficacy of Etifoxine in Adults with Adjustment Disorder with Anxiety: A Randomized, Double‑Blind, Placebo‑Controlled Trial
RomaniaA study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
RomaniaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
RomaniaStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
RomaniaStudy on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)
RomaniaStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
RomaniaComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
RomaniaStudy on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on moderate to severe asthma treatments, evaluating new inhaler formulations and their safety profiles. Studies aim to improve bronchodilation and reduce exacerbations in patients following GINA guidelines.
Multiple trials examining maintenance therapy optimization for better patient outcomes.
Comprehensive studies exploring chronic obstructive pulmonary disease treatments, including evaluation of triple combination therapies and novel biological agents for moderate to severe cases.
Focus on improving quality of life for patients with chronic respiratory conditions.
Investigation of targeted treatments for severe eosinophilic asthma and development of innovative rescue medications. Research includes long-term efficacy studies of biological treatments.
Emphasis on personalized treatment approaches for specific patient populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
